GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Modus Therapeutics Holding AB (OSTO:MODTX) » Definitions » Common Stock

Modus Therapeutics Holding AB (OSTO:MODTX) Common Stock : kr2.16 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Modus Therapeutics Holding AB Common Stock?

Modus Therapeutics Holding AB's quarterly common stock stayed the same from Mar. 2024 (kr2.16 Mil) to Jun. 2024 (kr2.16 Mil) and stayed the same from Jun. 2024 (kr2.16 Mil) to Sep. 2024 (kr2.16 Mil).

Modus Therapeutics Holding AB's annual common stock stayed the same from Dec. 2021 (kr0.97 Mil) to Dec. 2022 (kr0.97 Mil) but then increased from Dec. 2022 (kr0.97 Mil) to Dec. 2023 (kr2.16 Mil).


Modus Therapeutics Holding AB Common Stock Historical Data

The historical data trend for Modus Therapeutics Holding AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modus Therapeutics Holding AB Common Stock Chart

Modus Therapeutics Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
1.19 0.04 0.97 0.97 2.16

Modus Therapeutics Holding AB Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 2.16 2.16 2.16 2.16

Modus Therapeutics Holding AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Modus Therapeutics Holding AB Business Description

Traded in Other Exchanges
N/A
Address
Olof Palmes gata 29 IV, Stockholm, SWE, 111 22
Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation as well as states of anemia, related to chronic inflammation such as kidney diseases through its patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.

Modus Therapeutics Holding AB Headlines

No Headlines